Leflunopharm 20 mg Filmtabletten Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

leflunopharm 20 mg filmtabletten

Leflunopharm 10 mg Filmtabletten Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

leflunopharm 10 mg filmtabletten

Leflunomid Tillomed 10 mg Tabletten Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

leflunomid tillomed 10 mg tabletten

Leflunomid Tillomed 20 mg Tabletten Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

leflunomid tillomed 20 mg tabletten

L.C.E. SANDOZ 200/50/200 levodopa 200 mg, carbidopa (as carbidopa monohydrate) 50 mg and entacapone 200 mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

l.c.e. sandoz 200/50/200 levodopa 200 mg, carbidopa (as carbidopa monohydrate) 50 mg and entacapone 200 mg film-coated tablet bottle

sandoz pty ltd - carbidopa monohydrate, quantity: 54.1 mg (equivalent: carbidopa, qty 50 mg); levodopa, quantity: 200 mg; entacapone, quantity: 200 mg - tablet, film coated - excipient ingredients: mannitol; titanium dioxide; sucrose; magnesium stearate; croscarmellose sodium; glycerol; povidone; iron oxide red; maize starch; hypromellose; polysorbate 80 - l.c.e. sandoz 200/50/200 is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.

L.C.E. SANDOZ 150/37.5/200 levodopa 150 mg, carbidopa (as carbidopa monohydrate) 37.5 mg and entacapone 200 mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

l.c.e. sandoz 150/37.5/200 levodopa 150 mg, carbidopa (as carbidopa monohydrate) 37.5 mg and entacapone 200 mg film-coated tablet bottle

sandoz pty ltd - carbidopa monohydrate, quantity: 40.5 mg (equivalent: carbidopa, qty 37.5 mg); entacapone, quantity: 200 mg; levodopa, quantity: 150 mg - tablet, film coated - excipient ingredients: iron oxide yellow; croscarmellose sodium; povidone; magnesium stearate; polysorbate 80; glycerol; sucrose; iron oxide red; hypromellose; mannitol; titanium dioxide; maize starch - l.c.e. sandoz 150/37.5/200 is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.

L.C.E. SANDOZ 125/31.25/200 levodopa 125 mg, carbidopa (as carbidopa monohydrate) 31.25 mg and entacapone 200 mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

l.c.e. sandoz 125/31.25/200 levodopa 125 mg, carbidopa (as carbidopa monohydrate) 31.25 mg and entacapone 200 mg film-coated tablet bottle

sandoz pty ltd - carbidopa monohydrate, quantity: 33.8 mg (equivalent: carbidopa, qty 31.25 mg); levodopa, quantity: 125 mg; entacapone, quantity: 200 mg - tablet, film coated - excipient ingredients: glycerol; titanium dioxide; croscarmellose sodium; sucrose; magnesium stearate; polysorbate 80; mannitol; maize starch; povidone; iron oxide red; hypromellose - l.c.e. sandoz 125/31.25/200 is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.

L.C.E. SANDOZ 100/25/200 levodopa 100 mg, carbidopa (as carbidopa monohydrate) 25 mg and entacapone 200 mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

l.c.e. sandoz 100/25/200 levodopa 100 mg, carbidopa (as carbidopa monohydrate) 25 mg and entacapone 200 mg film-coated tablet bottle

sandoz pty ltd - carbidopa monohydrate, quantity: 27 mg (equivalent: carbidopa, qty 25 mg); levodopa, quantity: 100 mg; entacapone, quantity: 200 mg - tablet, film coated - excipient ingredients: povidone; iron oxide yellow; croscarmellose sodium; mannitol; glycerol; maize starch; titanium dioxide; magnesium stearate; polysorbate 80; hypromellose; sucrose; iron oxide red - l.c.e. sandoz 100/25/200 is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.

L.C.E. SANDOZ 75/18.75/200 levodopa 75 mg, carbidopa (as carbidopa monohydrate) 18.75 mg and entacapone 200 mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

l.c.e. sandoz 75/18.75/200 levodopa 75 mg, carbidopa (as carbidopa monohydrate) 18.75 mg and entacapone 200 mg film-coated tablet bottle

sandoz pty ltd - carbidopa monohydrate, quantity: 20.25 mg (equivalent: carbidopa, qty 18.75 mg); entacapone, quantity: 200 mg; levodopa, quantity: 75 mg - tablet, film coated - excipient ingredients: polysorbate 80; maize starch; hypromellose; croscarmellose sodium; iron oxide red; titanium dioxide; povidone; magnesium stearate; glycerol; mannitol; sucrose - l.c.e. sandoz 75/18.75/200 is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.

L.C.E. SANDOZ 50/12.5/200 levodopa 50 mg, carbidopa (as carbidopa monohydrate) 12.5 mg and entacapone 200 mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

l.c.e. sandoz 50/12.5/200 levodopa 50 mg, carbidopa (as carbidopa monohydrate) 12.5 mg and entacapone 200 mg film-coated tablet bottle

sandoz pty ltd - levodopa, quantity: 50 mg; carbidopa monohydrate, quantity: 13.5 mg (equivalent: carbidopa, qty 12.5 mg); entacapone, quantity: 200 mg - tablet, film coated - excipient ingredients: hypromellose; mannitol; titanium dioxide; magnesium stearate; povidone; maize starch; sucrose; iron oxide red; glycerol; iron oxide yellow; polysorbate 80; croscarmellose sodium - l.c.e. sandoz 50/12.5/200 is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.